Drugs & Targets Novartis receives positive CHMP opinion for Kymriah for DLBCL, B-cell ALL July 06, 2018Vol.44 No.27
Drugs & Targets FDA grants Priority Review for Keytruda + chemotherapy as first-line for squamous NSCLC July 06, 2018Vol.44 No.27
Drugs & Targets Lynparza approved in Japan for BRCA-mutated metastatic breast cancer July 06, 2018Vol.44 No.27
Drugs & Targets FDA approves Braftovi + Mektovi combination in a melanoma indication June 29, 2018Vol.44 No.26
Drugs & Targets Kymab, Roche agree to evaluate KY1044, anti-PD-L1 immunotherapy in solid tumors June 29, 2018Vol.44 No.26
Drugs & Targets FDA grants orphan drug designation for CPI-613 for Burkitt lymphoma June 29, 2018Vol.44 No.26
Drugs & TargetsFree FDA to review BRACAnalysis CDx sPMA as companion diagnostic for Talazoparib June 22, 2018Vol.44 No.25
Drugs & TargetsFree China’s drug agency approves Opdivo for previously treated NSCLC June 22, 2018Vol.44 No.25
Drugs & TargetsFree Natera, Institut Jules Bordet to collaborate on neoadjuvant breast cancer assay June 22, 2018Vol.44 No.25
Drugs & Targets FDA approves Avastin in combination with chemotherapy for ovarian cancer June 15, 2018Vol.44 No.24
